计算药物重新定位IL6触发了JAK3在类风湿性关节炎使用FDA数据库
Kaushani Banerjee1, Bavya Chandrasekar1, Sruthy Sathish1
1Computational Biology Lab, Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, SRM Nagar, Potheri, Kattankulathur, Chengalpattu District, Tamil Nadu, 603203, India.
Molecular diversity
|August 14, 2024
概括
这项研究确定了三种FDA批准的药物,这些药物针对Janus激酶3 (JAK3) 信号,用于类风湿性关节炎 (RA) 治疗. 这些化合物具有很高的结合亲和力和选择性,为RA患者提供潜在的新疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
背景情况:
- 风湿性关节炎 (RA) 是一种普遍的自身免疫性疾病,影响全球人口的0.5-1%,在35-50岁的女性中发病率更高.
- 破坏的Janus激酶3 (JAK3) 信号与RA的发病有关,这表明JAK3是免疫抑制的特定治疗标.
研究的目的:
- 通过向JAK3蛋白和JAK/STAT信号通路,识别可用于类风湿性关节炎治疗的现有FDA批准的药物.
- 评估潜在候选药物对JAK的选择性和结合亲和力3.
主要方法:
- 通过分子对接对JAK3蛋白进行FDA批准的化合物的选.
- 交叉对接分析以评估蛋白质选择性.
- 密度功能理论 (DFT) 和分子动力学模拟,以评估在原子层面上的药物相似性.
主要成果:
- 识别具有高结合亲和力和对JAK的选择性的化合物3.
- 计算分析证实了所选化合物的药物相似性.
- 三种FDA批准的药物被确定为RA的潜在治疗选择.
结论:
- 该研究成功地确定了三种FDA批准的药物,这些药物通过向抑制JAK3.3,有可能治疗类风湿性关节炎.
- 这些重新设计的药物通过JAK/STAT通路专门抑制免疫系统,为治疗RA提供了一个有希望的途径.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
T Cell Types and Functions
964
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
964


